Artigos de Revisão

Indications for Atrial Fibrillation Ablation: A Practical Guide for Non-Cardiologists

Conteúdo principal do artigo

Pedro Silva Cunha
Gustavo Rocha Rodrigues
Francisco Morgado
Palavras-chave:
Fribrilhação Auricular, Ablação por Cateter

Resumo

Dado o significativo aumento na incidência da fibrilhação auricular, e a crescente divulgação da ablação por cateter como método de tratamento não-farmacológico desta arritmia, foi nossa intenção escrever um guia prático para médicos não-cardiologistas sobre as principais indicações para esta intervenção à luz das presentes guidelines.

Detalhes do artigo

Como Citar
Secção
Artigos de Revisão

Referências

- Imberti JF, Ding WY, Kotalczyk A, Zhang J, Boriani G, Lip G, et al. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021;107:1630-6. doi: 10.1136/heartjnl-2021-319496.

- Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61:1713-23. doi: 10.1016/j.jacc.2012.11.064.

- Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, et al. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321:1275-85. doi: 10.1001/jama.2019.0692. Erratum in: JAMA. 2019;321:2370. doi: 10.1001/jama.2019.7682.

- Blomström-Lundqvist C, Gizurarson S, Schwieler J, Jensen SM, Bergfeldt L, Kennebäck G, et al. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial. JAMA. 2019;321:1059-68. doi: 10.1001/jama.2019.0335.

- Wynn GJ, Das M, Bonnett LJ, Panikker S, Wong T, Gupta D. Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials. Circ Arrhythm Electrophysiol. 2014;7:841-52. doi: 10.1161/CIRCEP.114.001759.

- Kochhäuser S, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, et al. Impact of acute atrial fibrillation termination and prolongation of atrial fibrillation cycle length on the outcome of ablation of persistent atrial fibrillation: A substudy of the STAR AF II trial. Heart Rhythm. 2017;14:476-83. doi: 10.1016/j.hrthm.2016.12.033.

- Brooks AG, Stiles MK, Laborderie J, Lau DH, Kuklik P, Shipp NJ, et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm. 2010;7:835-46. doi: 10.1016/j.hrthm.2010.01.017.

- Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018;378:417-27. doi: 10.1056/NEJMoa1707855.

- Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373-498. doi: 10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021;42:507. doi: 10.1093/eurheartj/ehaa798. Erratum in: Eur Heart J. 2021;42:546-7. doi: 10.1093/eurheartj/ehaa945. Erratum in: Eur Heart J. 2021;42:4194. doi: 10.1093/eurheartj/ehab648.